Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Inhibition of the constitutively active PI3K/Akt/mTOR signaling pathway in epstein-barr virus B cell lymphomas demonstrate both antitumor and antirejection properties Sang, A., Ivison, G. T., Qu, X., Esquivel, C. O., Krams, S. M., Martinez, O. M. LIPPINCOTT WILLIAMS & WILKINS. 2016: S258
View details for Web of Science ID 000436953200402